Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 27.22 | N/A |
| PEG Ratio (TTM) | -1.25 | N/A |
| P/S Ratio (TTM) | 0.62 | N/A |
| P/B Ratio (TTM) | 9.98 | N/A |
| P/FCF Ratio (TTM) | 13.92 | N/A |
| Price to 5YR AVG Earnings Ratio | 6.58 | N/A |
| Price to 5YR AVG FCF Ratio | 9.04 | N/A |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.99% | N/A |
| ROE (TTM) | 30.69% | N/A |
| Net Profit Margin (TTM) | 2.28% | N/A |
| ROIC 5YR AVG | 46.77% | N/A |
Growth (88%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 74.49% | 69.17% | 41.65% |
| Revenue | -4.65% | 14.08% | 15.35% |
| Net Income | 72.40% | 59.97% | 34.96% |
| Cash Flow | 19.37% | 17.15% | 38.22% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.37 | N/A |
| Quick Ratio (TTM) | 0.57 | N/A |
| D/E Ratio (TTM) | 5.39 | N/A |
| Interest Coverage (TTM) | 3.41 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 2.14 | N/A |
| LTL to 5YR AVG FCF | 7.00 | N/A |
| Shares Outstanding Growth 5YR AVG | -4.38% | N/A |